Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P010014/S109

Oxford Partial Knee System

Biomet Manufacturing Corp · Decision date Aug 7, 2025

FDA DECISIONP010014/S109

What did the FDA approve?

FDA records P010014/S109 as a supplement to PMA P010014, with the supplement type “Normal 180 Day Track”. The recorded decision is approval, dated Aug 7, 2025.

FDA approval order statement

approval for new Cemented and Cementless versions of the Oxford Partial Knee System Tibial Tray component (referred to as the Oxford Anatomic Tibial components).
Regulatory pathway
PMA supplement
Supplement type
Normal 180 Day Track
Clinical specialty
Orthopedic
Decision date
Aug 7, 2025
FDA change category
Change Design/Components/Specifications/Material

FDA source record

Regulatory record facts

Identifier
P010014/S109
Regulatory pathway
PMA supplement
Product code
NRA
Decision code
APPR
Decision date
Aug 7, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Prosthesis, knee, femorotibial, unicompartmental, semi-constrained, metal/polymer, mobile bearing.

Product code
NRA
FDA device class
3

For the original device and its historical approval scope, see PMA P010014. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P010014 · Original PMA

    OXFORD(TM) MENISCAL UNICOMPARTMENTAL KNEE SYSTEM

  2. P010014/S109 received

    Application receipt date recorded by FDA.

  3. P010014/S109 · FDA decision

    Normal 180 Day Track

  4. P010014/S113 · Related supplement

    Oxford Partial Knee System

  5. P010014/S114 · Related supplement

    Oxford Cementless Partial Knee System

  6. P010014/S115 · Related supplement

    Oxford Partial Knee System

  7. P010014/S116 · Related supplement

    Oxford Partial Knee System

  8. P010014/S112 · Related supplement

    Oxford Partial Knee System; Cementless OxfordPartial Knee System

  9. P010014/S117 · Related supplement

    Oxford Partial Knee System

  10. P010014/S118 · Related supplement

    Oxford Partial Knee Anatomic Vivacit-E Meniscal Bearings

  11. P010014/S119 · Related supplement

    Cementless Oxford Partial Knee System

  12. P010014/S120 · Related supplement

    Oxford Partial Knee System

Timeline entries are records held by MedtechLedger for P010014. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P010014

Product / regulatory recordCompanyPathwayDecision dateSource
Biomet Manufacturing CorpPMA approvalApr 21, 2004FDA
Oxford Knee SystemP010014/S111
Biomet Manufacturing CorpPMA supplementAug 7, 2025FDA
Biomet Manufacturing CorpPMA supplementJan 16, 2026FDA
Biomet Manufacturing CorpPMA supplementMar 6, 2026FDA
Biomet Manufacturing CorpPMA supplementApr 20, 2026FDA
Biomet Manufacturing CorpPMA supplementMay 12, 2026FDA
Biomet Manufacturing CorpPMA supplementMay 27, 2026FDA
Biomet Manufacturing CorpPMA supplementJul 13, 2026FDA
Biomet Manufacturing CorpPMA supplementSep 1, 2026FDA
Biomet Manufacturing CorpPMA supplementOct 6, 2026FDA
Biomet Manufacturing CorpPMA supplementOct 26, 2026FDA

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Biomet Manufacturing Corp

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
56 E. Bell Dr.,, P.O. Box 587, Warsaw, IN, 46581

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records